Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
We investigate, we move forward: the 2025 Impact Report is now available
In this document we summarise the most important activities of 2025, a year marked by significant scientific advances in the field of Alzheimer's, support for affected individuals and families, and the growth of social support for our cause
The BBRC hosted the second scientific session of the Barcelona Alzheimer’s HUB, focusing on fluid biomarkers
The Barcelona Alzheimer’s HUB, supported by the Pasqual Maragall Foundation and the Barcelonaβeta Brain Research Center, held the second session of its scientific series at its headquarters, focusing on the study of fluid biomarkers.
How the environment influences biological brain ageing
An international study involving data from the ALFA+ cohort shows that the combination of physical and social environmental exposures is a major driver of accelerated or delayed brain aging.
Alzheimer’s genetic risk affects women and men differently years before symptoms appear
A study by the BBRC shows that the genetic risk of Alzheimer’s disease may manifest itself differently in women and men, paving the way for more personalised prevention strategies.
The Pasqual Maragall Foundation opens a new call in collaboration with the Alzheimer’s Association
The call provides up to €400,000 for clinical and translational research in Alzheimer’s disease and related dementias
The BBRC participates in the 20th edition of AD/PD
BBRC researchers contributed to the AD/PD 2026 International Conference with four oral presentations and two posters.
The Barcelonaβeta Brain Research Center incorporates a new population neuroscience group led by Dr. Tomáš Paus and Dr. Zdenka Pausova
The BBRC consolidates seven groups and expands its focus toward prevention and brain health from a comprehensive and longitudinal perspective
Dr. Marc Suárez delivers plenary session at AAIC Neuroscience Next 2026
During his presentation, he highlighted biomarker advances, from biology to their application in patients and clinical settings.
BBRC researchers take part in a Nature Aging study validating blood biomarkers in diverse populations
The study strengthens the validity of blood-based biomarkers for detecting Alzheimer’s disease and other dementias in diverse population settings, representing a key step towards more accessible and equitable diagnosis
